Skip to main content Back to Top
Advertisement

4/12/2018

Melphalan Tablets

Products Affected - Description

    • Alkeran oral tablet, Apo-Pharma, 2 mg, glass bottle, 50 count, NDC 52609-0001-05

Reason for the Shortage

    • Apo-Pharma did not provide a reason for the Alkeran tablets shortage.

Available Products

    • Melphalan oral tablet, Alvogen, 2 mg, bottle, 50 count, NDC 47781-0200-50

Estimated Resupply Dates

    • Apo-Pharma has Alkeran oral tablets on back order and the company cannot estimate a release date.
    • Alvogen has melphalan oral tablets available with expiration dating of March 2019.

Updated

Updated April 12, 2018 by Elyse MacDonald, PharmD, MS, BCPS. Created December 28, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.